| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/30/2014 | WO2014018926A1 Methods and compositions for determining resistance to androgen receptor therapy |
| 01/30/2014 | WO2014018904A1 Fused antigen vaccines and compositions against streptococcus pneumoniae |
| 01/30/2014 | WO2014018863A1 Engineering t-cell receptors |
| 01/30/2014 | WO2014018858A2 Multimeric fusion protein vaccine and immunotherapeutic |
| 01/30/2014 | WO2014018853A1 Novel insecticidal proteins and methods for their use |
| 01/30/2014 | WO2014018850A2 Cytoplasmic tail modifications to boost surface expression and immunogenicity of envelope glycoproteins |
| 01/30/2014 | WO2014018724A1 Tick toxin compositions |
| 01/30/2014 | WO2014018601A2 New modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins |
| 01/30/2014 | WO2014018278A2 Multisignal reagents for labeling analytes |
| 01/30/2014 | WO2014018120A1 Modified factor x polypeptides and uses thereof |
| 01/30/2014 | WO2014018117A1 An mva vaccine for delivery of a ul128 complex and preventing cmv infection |
| 01/30/2014 | WO2014018079A1 Method of treating hyperglycemic disorders using apoliprotein aiv |
| 01/30/2014 | WO2014018018A1 Composition and method for reducing tissue damage from inflammatory disorder or pathogenic infection |
| 01/30/2014 | WO2014017698A1 High-yield and high-purity amyloid-beta peptide production method |
| 01/30/2014 | WO2014017493A1 Vaccine |
| 01/30/2014 | WO2014017491A1 Fusion gene of cep55 gene and ret gene |
| 01/30/2014 | WO2014017474A1 Collagen peptide composition production method, dpp-4 inhibitor, and antihyperglycemic agent |
| 01/30/2014 | WO2014017394A1 Novel iron-zinc binding control factor, and technique for improving iron deficiency tolerance of plant and enhancing iron and zinc accumulation in edible part thereof by controlling expression of novel iron-zinc binding control factor |
| 01/30/2014 | WO2014017319A1 Filaggrin production promoter, therapeutic agent for diseases associated with reduction in production of filaggrin, and method for screening for said therapeutic agent |
| 01/30/2014 | WO2014017106A1 Compositions Comprising RAC Mutants, and Methods of Use Thereof |
| 01/30/2014 | WO2014016829A1 Insoluble fibrinogen particles (ifp) and coatings : composition, fabrication methods, and applications for harvesting and culturing mammalian cells |
| 01/30/2014 | WO2014016673A1 Sodium channel blocking peptides and the use thereof |
| 01/30/2014 | WO2014016455A1 Variants of the calcium-sensitive fusion protein tdtomato-aequorin |
| 01/30/2014 | WO2014016417A1 Hmgb1 variants and uses thereof |
| 01/30/2014 | WO2014016383A2 Glycoproteins for pseudotyping lentivectors |
| 01/30/2014 | WO2014016312A1 Hpv/cyaa-based chimeric proteins and their uses in the induction of immune responses against hpv infection and hpv-induced disorders |
| 01/30/2014 | WO2014016300A1 Glucagon analogues |
| 01/30/2014 | WO2014015831A1 Tumor antigenic peptide and application of same as tumor vaccine |
| 01/30/2014 | WO2014015388A1 A method for polishing albumin |
| 01/30/2014 | WO2013155526A3 Sortase- modified vhh domains and uses thereof |
| 01/30/2014 | WO2013128418A3 Peptide inhibitors as novel anti-hiv therapeutics |
| 01/30/2014 | US20140033371 Sulfonylurea-responsive repressor proteins |
| 01/30/2014 | US20140033363 Axmi238 toxin gene and methods for its use |
| 01/30/2014 | US20140033361 Novel Insecticidal Proteins and Methods for Their Use |
| 01/30/2014 | US20140031532 Purification of cell culture derived alpha1 protease inhibitor |
| 01/30/2014 | US20140031530 Glycoprotein homone long-acting superagonists |
| 01/30/2014 | US20140031527 Method for polishing albumin |
| 01/30/2014 | US20140031526 High Molecular Ordered Fibrilar Structures, Method for Their Preparation and Uses Thereof |
| 01/30/2014 | US20140031525 Mutant g-protein coupled receptor proteins and methods for producing them |
| 01/30/2014 | US20140031522 Novel alkali-resistant variants of protein a and their use in affinity chromatography |
| 01/30/2014 | US20140031521 Plant myb transcription factor homologs |
| 01/30/2014 | US20140031520 Targeting vector-phospholipid conjugates |
| 01/30/2014 | US20140031294 Recombinant transferrin mutants |
| 01/30/2014 | US20140031292 Yeast Cell Surface Display of Proteins and Uses Thereof |
| 01/30/2014 | US20140031284 Neuregulin variants and methods of screening and using thereof |
| 01/30/2014 | US20140031283 Anticancer fusion protein |
| 01/30/2014 | US20140031279 Human Insulin Analogues and Derivatives Comprising Cysteine Substitutions |
| 01/30/2014 | US20140031278 Novel Glucagon Analogues |
| 01/30/2014 | US20140031277 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/30/2014 | US20140031247 Methods and compositions for gamma-secretase assay |
| 01/30/2014 | US20140030787 Multisignal reagents for labeling analytes |
| 01/30/2014 | US20140030742 Antibody reacting with native cochlin-tomoprotein (ctp) and method for measuring ctp using same |
| 01/30/2014 | US20140030702 Modified influenza virus for monitoring and improving vaccine efficiency |
| 01/30/2014 | US20140030319 Antagonists Of The Oncongenic Activity Of The Protein MDM2, And Use Thereof In the Treatment of Cancers |
| 01/30/2014 | US20140030293 New adjuvant |
| 01/30/2014 | US20140030292 Antigen delivery platforms |
| 01/30/2014 | US20140030290 Infectious Clones of RNA Viruses and Vaccines and Diagnostic Assays Derived Thereof |
| 01/30/2014 | US20140030286 Peptides capable of forming a convalent complex, and uses thereof |
| 01/30/2014 | US20140030285 Altered OSPA of Borrelia Burgdorferi |
| 01/30/2014 | US20140030272 Methods for Diagnosing and Treating Iron Dysregulation |
| 01/30/2014 | US20140030267 Compositions, methods and kits relating to resistin |
| 01/30/2014 | US20140030265 Modified soluble fgf receptor fc fusions method |
| 01/30/2014 | US20140030264 Vaccines directed to langerhans cells |
| 01/30/2014 | US20140030225 Derivatives of growth hormone and related proteins, and methods of use thereof |
| 01/30/2014 | US20140030222 Recombinant fusion interferon for animals |
| 01/30/2014 | US20140030213 Process for Purification of Recombinant Granulocyte Colony Stimulating Factor (RHU GCSF) |
| 01/29/2014 | EP2690173A1 Protein for affinity-separation matrix |
| 01/29/2014 | EP2690110A1 Purification of cell culture derived alpha1 protease inhibitor |
| 01/29/2014 | EP2690109A1 Modified microorganism for high efficient production of 1,4-butanediol |
| 01/29/2014 | EP2690108A1 Novel immunoglobulin-binding polypeptide |
| 01/29/2014 | EP2689786A1 HPV/CYAA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders |
| 01/29/2014 | EP2689022A1 Compositions and methods for enhancing the pluripotency of stem cells |
| 01/29/2014 | EP2689018A1 Constructs and method for regulating gene expression or for detecting and controlling a dna locus in eukaryotes |
| 01/29/2014 | EP2689016A1 Immunogenic compositions in particulate form and methods for producing the same |
| 01/29/2014 | EP2689010A1 Method and compositions for cellular immunotherapy |
| 01/29/2014 | EP2688908A1 Targeted cytokine for treatment of musculoskeletal diseases |
| 01/29/2014 | EP2688907A1 Dominant negative hsp110 mutant and its use in prognosing and treating cancers |
| 01/29/2014 | EP2688906A2 Plant regulatory elements and uses thereof |
| 01/29/2014 | EP2688905A1 Peptides capable of forming a covalent complex, and uses thereof |
| 01/29/2014 | EP2688904A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy |
| 01/29/2014 | EP2688903A1 Method of recovering plant-derived proteins |
| 01/29/2014 | EP2688586A2 Plasmodium falciparum antigens |
| 01/29/2014 | EP2344537B1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 01/29/2014 | EP2001903B1 Long-acting polypeptides and methods of producing and administering same |
| 01/29/2014 | EP1451292B1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted |
| 01/29/2014 | EP1196638B1 Use of the krit1 gene in angiogenesis |
| 01/29/2014 | CN103548166A Method for producing protein semiconductor |
| 01/29/2014 | CN103547676A Immunogenic compositions in particulate form and methods for producing the same |
| 01/29/2014 | CN103547672A Thermostable carbonic anhydrases and methods of use thereof |
| 01/29/2014 | CN103547591A Growth hormone releasing factor (GRF) analogs and uses thereof |
| 01/29/2014 | CN103547590A Highly soluble leptins |
| 01/29/2014 | CN103547296A Molecules and methods for inhibition and detection of proteins |
| 01/29/2014 | CN103547283A HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof |
| 01/29/2014 | CN103540613A Multi plasmid system for the production of influenza virus |
| 01/29/2014 | CN103540603A Biosynthetic gene cluster of aureonuclemycin and application thereof |
| 01/29/2014 | CN103540598A Aspergillus nidulans ANakr gene and use thereof |
| 01/29/2014 | CN103540588A Genetic engineering modified immunoglobulin-affinity protein |
| 01/29/2014 | CN103540568A Multi plasmid system for the production of influenza virus |
| 01/29/2014 | CN103540560A Recombinant bacterium and application thereof |
| 01/29/2014 | CN103539859A Self-assembled polypeptide nanometer for preparing contraception vaccine |